Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma

NeuGc-containing gangliosides have been described in melanoma cells and are an attractive target for cancer immunotherapy because they are minimally or not expressed in normal human tissues. Melanoma patients treated with a vaccine based on N-glycolyl gangliosides have shown benefit in progression f...

Descripción completa

Detalles Bibliográficos
Autores principales: Osorio, Marta, Gracia, Elias, Reigosa, Edmundo, Hernandez, Julio, de la Torre, Ana, Saurez, Giselle, Perez, Kirenia, Viada, Carmen, Cepeda, Meylán, Carr, Adriana, Ávila, Yisel, Rodríguez, Migdalia, Fernandez, Luis E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468021/
https://www.ncbi.nlm.nih.gov/pubmed/23055778
http://dx.doi.org/10.2147/CMAR.S22617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468021/
https://www.ncbi.nlm.nih.gov/pubmed/23055778
http://dx.doi.org/10.2147/CMAR.S22617

Ejemplares similares